EV Biologics Inc (YECO)
0.6221
+0.02
(+3.32%)
USD |
OTCM |
Apr 26, 15:04
EV Biologics Cash and Short Term Investments (Quarterly): 1.729M for Dec. 31, 2017
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | 1.729M |
| December 31, 2016 | 2.478M |
| September 30, 2016 | 2.664M |
| June 30, 2016 | 2.734M |
| March 31, 2016 | 31.76M |
| December 31, 2015 | 29.73M |
| Date | Value |
|---|---|
| September 30, 2015 | 30.32M |
| June 30, 2015 | 16.47M |
| March 31, 2015 | 15.99M |
| December 31, 2014 | 8.054M |
| September 30, 2014 | 23.06M |
| June 30, 2014 | 19.73M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| CEL-SCI Corp | 3.241M |
| AIM ImmunoTech Inc | 13.07M |
| IGC Pharma Inc | 1.378M |
| NovaBay Pharmaceuticals Inc | 3.13M |
| Protalix BioTherapeutics Inc | 44.56M |